This is not a minor difference
Many also noted better eating habits (65%) and improved mental health (60%), reinforcing the idea that GLP-1s may offer more than just weight loss
As a society, we need to explore how better care management solutions can produce long-term benefits for all patients
In PIONEER 4, patients taking the highest dose of oral semaglutide (14 mg daily) achieved average weight loss of 10-12% of their body weight over 68 weeksresults comparable to injectable GLP-1 therapy
After drawing, tap the barrel firmly while holding it needle-up to float bubbles to the top
GSEA analysis on the effect of tirzepatide on fatty acid metabolism showed that tirzepatide treatment exerted no significant effect on the mRNA expression of genes involved in fatty acid synthesis (SREBP2, FASN, ACC1, and SCD-1), fatty acid transport (FATP4 and FATP5), lipolysis (Mgll, Lipe, and ATGL), or inflammation (TNF, IL-1, and IL-6), suggesting that tirzepatide has limited effects on multiple metabolic pathways. Since metabolic dysregulation in MASLD also involves the extra-hepatic tissues, the authors analyzed the effect of tirzepatide on white & brown adipose tissues and skeletal muscle